secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celldex Therapeutics, Inc. (CLDX)
CIK:        0000744218
Form:       8-K
Filed at:   2026-07-15T20:07:43+00:00
Accession:  0001104659-26-083880
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Celldex Therapeutics CFO Sam Martin to retire by March 31, 2027; search underway
--------------------------------------------------------------------------------

- Sam Martin, SVP and CFO, notified of his retirement effective on or about March 31, 2027.
- Martin joined Celldex in April 2009 and has served as CFO since July 2017.
- Company has initiated a search for a new CFO; Martin will continue until successor or March 31, 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744218/000110465926083880/0001104659-26-083880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744218/000110465926083880/tm2620527d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-083880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer